
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Infini ASI is a seed fund based in Poland, established to commercialize research projects and support innovative startups. Founded in 2020, the organization focuses on helping early-stage companies navigate the complexities of market entry. Infini ASI aims to bolster the Polish startup ecosystem by investing in promising ideas and providing essential resources for growth.
The fund currently manages a portfolio of six companies and has a capital investment capacity of up to 1 million PLN (approximately $250K) per project. Infini ASI operates from two office locations in Poland: Białystok and Warsaw. The firm has made significant strides in supporting startups through various stages of development, emphasizing research, analysis, and prototype development.
Notable milestones include the successful launch of several portfolio companies that have made advancements in their respective sectors. Infini ASI's commitment to fostering innovation positions it as a key player in the European venture capital landscape.
Infini ASI invests primarily in early-stage projects across multiple sectors, including biotech, healthcare, consumer products, and SaaS. The fund targets pre-seed and seed stages, offering capital investments ranging from $0 to $250K. Infini ASI conducts a thorough preliminary verification of submitted ideas, followed by detailed project assessments that encompass research, analysis, and prototype development.
The fund's investment strategy emphasizes equity stakes in newly established companies, allowing for potential follow-on funding from private investors for successful projects. Infini ASI seeks founders who demonstrate a strong commitment to their ideas and possess the ability to execute their vision effectively. The firm values innovative solutions that address real-world problems, particularly in the sectors it focuses on.
Infini ASI has invested in a diverse array of companies, showcasing its commitment to supporting innovative solutions across various sectors. The portfolio includes:
These companies reflect Infini ASI's strategic focus on sectors that promise significant growth and innovation. The fund's involvement has been crucial in helping these startups develop their technologies and bring their products to market.
Maciej Wieloch: CEO and Member of the Investment Committee. Maciej has extensive experience in venture capital and startup development, having previously worked with several successful startups in Poland.
Ernest Wawryniuk: Vice President and Member of the Investment Committee. Ernest brings a wealth of knowledge in investment strategies and has a strong background in finance.
Piotr Soroka: Investment Manager. Piotr specializes in evaluating early-stage investments and has a keen eye for identifying promising startups.
Artur Badyda: Technology Broker. Artur focuses on bridging the gap between technology and market needs, ensuring that portfolio companies have the necessary support for development.
Katarzyna Vogel: Office Manager. Katarzyna oversees the daily operations of the fund and ensures smooth communication within the team.
Beata Stanula: Executive Assistant. Beata provides administrative support to the team and assists in managing investor relations.
Startups interested in pitching to Infini ASI should submit their proposals through the application form available at this link. The pitch deck should include a clear overview of the business model, market analysis, and financial projections. Infini ASI prefers concise and well-structured presentations that effectively communicate the startup's value proposition.
Response times may vary, but founders can expect feedback within a few weeks after submission. Warm introductions are beneficial but not mandatory for the application process.
As of March 2023, Infini ASI has continued to expand its portfolio, actively investing in innovative startups across various sectors. The fund has highlighted its commitment to supporting early-stage companies in Poland, particularly in biotech and healthcare.
Recent announcements include the successful funding rounds for portfolio companies such as Bioacoustic and FlyTech UAV, which have made significant advancements in their respective fields. Infini ASI remains focused on identifying and nurturing promising startups that align with its investment strategy.
What are Infini ASI's investment criteria?
Infini ASI invests in early-stage projects across biotech, healthcare, consumer products, and SaaS sectors. The fund focuses on pre-seed and seed stages, offering capital investments of up to 1 million PLN in exchange for equity.
How can startups apply for funding?
Startups can apply for funding through the application form available on Infini ASI's website at this link. The application process includes a preliminary verification of submitted ideas.
What makes Infini ASI different from other seed funds?
Infini ASI emphasizes thorough project verification, including research, analysis, and prototype development, which sets it apart from other seed funds. The firm also provides ongoing support to its portfolio companies throughout their development stages.
What is the geographic scope of Infini ASI's investments?
The fund primarily focuses on startups based in Europe, particularly those located in Poland, aligning with its mission to strengthen the local startup ecosystem.
What is the typical check size for investments?
Infini ASI typically invests between $0 and $250K in early-stage projects, with the potential for follow-on funding based on project success.
What kind of post-investment involvement does Infini ASI have?
Infini ASI actively supports its portfolio companies through various stages of development, providing resources for research, analysis, and prototype development, as well as facilitating connections with private investors for additional funding opportunities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.